A real-world observational retrospective cohort study of Canadian people living with HIV switching from nevirapine plus two nucleoside reverse transcriptase inhibitors to dolutegravir/lamivudine

被引：2
|
作者：
de Wet, Joseph J. [1 ,2 ]
Ban, Joann K. [3 ]
Verdier, Gustavo [4 ]
Ling, Juejing [5 ]
Eberg, Maria [5 ]
Bunko, Andrean [5 ]
McKimm, Michael [4 ,6 ]
机构：
[1] Spectrum Hlth, Vancouver, BC, Canada
[2] Univ British Columbia, Dept Family Practice, Vancouver, BC, Canada
[3] GSK, Mississauga, ON, Canada
[4] ViiV Healthcare, Montreal, PQ, Canada
[5] IQVIA, Kirkland, PQ, Canada
[6] ViiV Healthcare, 75 Queen St,Suite 1400, Montreal, PQ H3C2N6, Canada
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2023年 / 62卷 / 02期
关键词：
D O I：
10.1016/j.ijantimicag.2023.106839
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] HIV Treatment with the Two-Drug Regimen Dolutegravir Plus Lamivudine in Real-world Clinical Practice: A Systematic Literature Review
    Patel, Rickesh
    Evitt, Lee
    Mariolis, Ilias
    Di Giambenedetto, Simona
    Monforte, Antonella D'Arminio
    Casado, Jose
    Cabello Ubeda, Alfonso
    Hocqueloux, Laurent
    Allavena, Clotilde
    Barber, Tristan
    Jha, Diwakar
    Kumar, Rahul
    Kamath, Rahul Dinesh
    Vincent, Tia
    van Wyk, Jean
    Koteff, Justin
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (04) : 2051 - 2070
  • [22] Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir Plus Lamivudine for Switch Therapy in Patients with HIV-1 Infection: A Real-World Cohort Study
    Lin Gan
    Xiaoxin Xie
    Yanhua Fu
    Xiaoyan Yang
    Shujing Ma
    Linghong Kong
    Chunli Song
    Yebing Song
    Tingting Ren
    Hai Long
    Infectious Diseases and Therapy, 2023, 12 : 2581 - 2593
  • [23] Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir Plus Lamivudine for Switch Therapy in Patients with HIV-1 Infection: A Real-World Cohort Study
    Gan, Lin
    Xie, Xiaoxin
    Fu, Yanhua
    Yang, Xiaoyan
    Ma, Shujing
    Kong, Linghong
    Song, Chunli
    Song, Yebing
    Ren, Tingting
    Long, Hai
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (11) : 2581 - 2593
  • [24] Effectiveness and tolerability of the two-drug regimen dolutegravir plus lamivudine in people with HIV-1: a systematic literature review of real-world evidence from clinical practice
    Letang, Emilio
    Priest, Julie
    Di Giambenedetto, Simona
    Monforte, Antonella d'Arminio
    Casado, Jose
    Cabello-Ubeda, Alfonso
    Hocqueloux, Laurent
    Allavena, Clotilde
    Barber, Tristan J.
    Jha, Diwakar
    Kamath, Rahul Dinesh
    Sithamparanathan, Myooran
    van Wyk, Jean
    Evitt, Lee
    HIV MEDICINE, 2022, 23 : 37 - 38
  • [25] Impact of HBV serological status on HIV virological efficacy of two-drug antiretroviral regimens: A retrospective observational study on virologically suppressed people with HIV switching to lamivudine/dolutegravir
    Salvo, Pierluigi Francesco
    Ciccullo, Arturo
    Visconti, Elena
    Lombardi, Francesca
    Torti, Carlo
    Di Giambenedetto, Simona
    Baldin, Gianmaria
    HIV MEDICINE, 2025, 26 (04) : 650 - 653
  • [26] Real-world experience of dolutegravir-containing dual antiretroviral (ARV) therapy in people living with HIV (PLWH): a retrospective analysis
    Hickey, W.
    Shah, S.
    Asboe, D.
    Boffito, M.
    HIV MEDICINE, 2019, 20 : 22 - 22
  • [27] 12-month outcomes of dolutegravir (DTG) plus lamivudine (3TC) in ART-naive and pre-treated people living with HIV in Germany: real-world data from the German URBAN cohort
    Scholten, S.
    Noe, S.
    Wyen, C.
    Beer, D.
    Postel, N.
    Degen, O.
    Pauli, R.
    Hillenbrand, H.
    Westermayer, B.
    Dymek, K. M.
    Scherzer, J.
    HIV MEDICINE, 2021, 22 : 111 - 112
  • [28] DOLAVI study: real-world data (RWD) of dolutegravir plus lamivudine in naive HIV-1-infected patients (week 24)
    Hidalgo-Tenorio, C.
    Pasquau, J.
    Vinuesa, D.
    Ferra, S.
    Terron, A.
    SanJoaquin, I.
    Payeras, A.
    Martinez, O.
    Omar-Mohamed-Balgahata, M.
    De la Torre, J.
    Lopez-Lirola, A.
    Palomares, J.
    Blanco, J. R.
    Montero, M.
    Sequera, S.
    Garcia-Vallecillos, C.
    HIV MEDICINE, 2021, 22 : 130 - 131
  • [29] Dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide fumarate: Real-world Assessment of weight Gain in naive people living with HIV of Asian OrigiN (DRAGON study)
    Chen, Jang-Pin
    Chen, Tsung-Chia
    Hsih, Wen-Hsin
    Tsai, Mao-Song
    Yang, Chia-Jui
    Cheng, Shu-Hsing
    Lin, Yi-Chun
    Ma, Ping
    Zhao, Qingxia
    Zou, Meiyin
    Wu, Yi-Wen
    Huang, Miao-Hui
    Sheng, Wang-Huei
    Cheng, Chien-Yu
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 267 - 268
  • [30] Effectiveness of integrase strand transfer inhibitors among treatment-naive people living with HIV/AIDS in Guangdong, China: A real-world, retrospective cohort study
    Chen, Mingyu
    Liu, Cong
    Xie, Jinzhao
    Tang, Xiaoping
    Zhang, Yao
    Pan, Deng
    Zhong, Haidan
    Du, Peishan
    Li, Quanmin
    Li, Linghua
    Gu, Jing
    Cai, Weiping
    MEDICINE, 2024, 103 (23) : e38497
12345